Basic research

Effects of Escherichia coli outer membrane vesicles on proliferation of breast cancer cells and tumor growth of tumor-bearing mice

  • Lanxi WANG ,
  • Guanrong MA ,
  • Yongzhu JIANG ,
  • Xiulin CHANG ,
  • Liaoqiong FANG ,
  • Jin BAI
Expand
  • 1.State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016, China
    2.Chongqing Key Laboratory of Biomedical Engineering, Chongqing Medical University, Chongqing 400016, China
BAI Jin, E-mail: sajinbai@cqmu.edu.cn.

Received date: 2022-12-08

  Accepted date: 2023-06-01

  Online published: 2023-10-28

Abstract

Objective ·To analyze the effect of Escherichia coli outer membrane vesicle (E.coli-OMV) on the proliferation of 4T1 breast cancer cells in vitro and the inhibition of tumor growth in BALB/c-4T1 tumor-bearing mice in vivo. Methods ·OMVs were collected from the culture supernatant of E.coli and characterized. The uptake of E.coli-OMV by 4T1 cells was detected by fluorescent label tracking method. The effect of E.coli-OMV on 4T1 cell proliferation was detected by CCK-8 method. The effect of E.coli-OMV on 4T1 cell cycle was detected by flow cytometry. The BALB/c-4T1 tumor-bearing mouse models were established by subcutaneous inoculation, and the mice were divided into E.coli-OMV group and Control group, with 10 mice in each group. The mice in the E.coli-OMV group were injected with 0.25 mg/kg E.coli-OMV every 2 d, while the mice in the Control group were injected with equal doses of PBS. The changes in body weight, 40 d survival rate, tumor volume and tumor weight of the two groups of tumor-bearing mice were observed. The pathological morphology of the tumor tissues was evaluated by hematoxylin-eosin staining (H-E staining). The expression of proliferating cell nuclear antigen (PCNA) and CyclinD1 in tumor tissues was observed by immunohistochemical staining. Results ·E.coli-OMVwas spherical membrane vesicle structure with a particle size of (216.00±18.30) nm, which expressed E.coli outer membrane protein A (OmpA) and OmpC. Fluorescence microscopy results showed that 4T1 cells could intake E.coli-OMV. CCK-8 results showed that the inhibitory effect of E.coli-OMV on 4T1 cells was positively correlated with time-dose. Flow cytometry results showed that E.coli-OMV arrested the growth cycle of 4T1 cells in G0/G1 phase. In vivo experiments showed that compared with the Control group, body weight of mice in the E.coli-OMV group decreased slightly after the initial injection (P=0.031), and then recovered, while 40 d survival rate increased (P=0.037). The growth of tumor volume and weight of mice in E.coli-OMV group were lower than those in the Control group (P=0.041, P=0.004). Its tumor volume inhibition rate reached 29.69%, and tumor weight inhibition rate reached 49.81%. The results of H-E staining showed that nuclear splitting images of tumor tissues of mice in the E.coli-OMV group decreased compared to the Control group (P=0.038). The results of immunohistochemical staining showed that the positive expression of PCNA and CyclinD1 in the tumor tissues of mice in the E.coli-OMV group decreased compared to the Control group (P=0.031, P=0.002). Conclusion ·Both in vitro and in vivo studies show that E.coli-OMV can significantly inhibit the proliferation of 4T1 cells.

Cite this article

Lanxi WANG , Guanrong MA , Yongzhu JIANG , Xiulin CHANG , Liaoqiong FANG , Jin BAI . Effects of Escherichia coli outer membrane vesicles on proliferation of breast cancer cells and tumor growth of tumor-bearing mice[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023 , 43(10) : 1245 -1254 . DOI: 10.3969/j.issn.1674-8115.2023.10.004

References

1 KATSURA C, OGUNMWONYI I, KANKAM H K, et al. Breast cancer: presentation, investigation and management[J]. Br J Hosp Med (Lond), 2022, 83(2): 1-7.
2 AKRAM M, IQBAL M, DANIYAL M, et al. Awareness and current knowledge of breast cancer[J]. Biol Res, 2017, 50(1): 33.
3 LIANG S Y, WANG C, SHAO Y C, et al. Recent advances in bacteria-mediated cancer therapy[J]. Front Bioeng Biotechnol, 2022, 10: 1026248.
4 FISUSI F A, AKALA E O. Drug combinations in breast cancer therapy[J]. Pharm Nanotechnol, 2019, 7(1): 3-23.
5 SONG S, VUAI M S, ZHONG M. The role of bacteria in cancer therapy: enemies in the past, but allies at present[J]. Infect Agent Cancer, 2018, 13: 9.
6 王敏, 苏乌云. 治疗癌症的新型武器: 细菌[J]. 世界最新医学信息文摘(连续型电子期刊), 2019, 19(66): 102-103, 105.
6 WANG M, SU W Y, et al. Bacteria: a new weapon against cancer[J]. World Latest Medicine Information, 2019, 19(66): 102-103, 105.
7 SEDIGHI M, ZAHEDI BIALVAEI A, HAMBLIN M R, et al. Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities[J]. Cancer Med, 2019, 8(6): 3167-3181.
8 KIKUCHI Y, OBANA N, TOYOFUKU M, et al. Diversity of physical properties of bacterial extracellular membrane vesicles revealed through atomic force microscopy phase imaging[J]. Nanoscale, 2020, 12(14): 7950-7959.
9 邱晓涵, 李泳江, 吴军勇, 等. 细菌外膜囊泡: 疾病治疗的新途径[J]. 药学学报, 2021, 56(12): 3441-3450.
9 QIU X H, LI Y J, WU J Y, et al. Bacterial outer membrane vesicles: a new approach to diseases therapy[J]. Acta Pharmaceutica Sinica, 2021, 56(12): 3441-3450.
10 CHEN Q, BAI H Z, WU W T, et al. Bioengineering bacterial vesicle-coated polymeric nanomedicine for enhanced cancer immunotherapy and metastasis prevention[J]. Nano Lett, 2020, 20(1): 11-21.
11 CHEN Y, LIU L G, FU H, et al. Comparative proteomic analysis of outer membrane vesicles from Shigella flexneri under different culture conditions[J]. Biochem Biophys Res Commun, 2014, 453(4): 696-702.
12 TOYOFUKU M, NOMURA N, EBERL L. Types and origins of bacterial membrane vesicles[J]. Nat Rev Microbiol, 2019, 17(1): 13-24.
13 RUDNICKA M, NOSZCZY?SKA M, MALICKA M, et al. Outer membrane vesicles as mediators of plant-bacterial interactions[J]. Front Microbiol, 2022, 13: 902181.
14 胡慧冰, 侯昕宇, 贺牧野, 等. 细菌外膜囊泡包覆的载药纳米粒的制备及其小鼠鼻腔免疫效果评价[J]. 上海交通大学学报(医学版), 2018, 38(2): 155-160.
14 HU H B, HOU X Y, HE M Y, et al. Preparation of bacterial outer membrane vesicle coated nanoparticle loaded with drug and evaluation of its nasal immune effect in mice[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2018, 38(2): 155-160.
15 YAGHOUBI A, KHAZAEI M, HASANIAN S, et al. Bacteriotherapy in breast cancer[J]. Int J Mol Sci, 2019, 20(23): 5880.
16 FARKAS-HIMSLEY H, CHEUNG R. Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia[J]. Cancer Res, 1976, 36(10): 3561-3567.
17 STRZALKA W, ZIEMIENOWICZ A. Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation[J]. Ann Bot, 2011, 107(7): 1127-1140.
18 GOLIAS C H, CHARALABOPOULOS A, CHARALABOPOULOS K. Cell proliferation and cell cycle control: a mini review[J]. Int J Clin Pract, 2004, 58(12): 1134-1141.
Outlines

/